Harrington Discovery Institute
Overview
The Harrington Discovery Institute, part of The Harrington Project for Discovery & Development at University Hospitals in Cleveland, Ohio, is a non-profit medical institute with a mission to accelerate promising scientific discoveries into medicines. Established in 2012, it utilizes a blended non-profit/for-profit model to support physician-scientists by providing grant funding and expert guidance to bridge the gap between laboratory research and commercialization. It invests in and helps develop new treatments for a range of diseases, with a focus on unmet needs. The institute has an Investment Advisory Board and partners with for-profit entities, such as the Advent-Harrington Impact Fund and BioMotiv, to advance its portfolio projects toward clinical trials and commercialization.
Portfolio Companies
4
Website
harringtondiscovery.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Allyx Therapeutics, Inc. | May 2026 | Series A | Co-investor |
| Epitop | Oct 2024 | VC Round | Co-investor |
| PIC Therapeutics | Oct 2022 | Series A | Co-investor |
| Epitop | Apr 2022 | Seed | Co-investor |
| Allyx Therapeutics, Inc. | Jun 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.